{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,6]],"date-time":"2025-12-06T05:36:17Z","timestamp":1764999377843,"version":"3.46.0"},"reference-count":47,"publisher":"BMJ","issue":"8","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open"],"accepted":{"date-parts":[[2017,6,5]]},"published-print":{"date-parts":[[2017,8]]},"abstract":"<jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>Guidelines recommend ACE inhibitors (ACEi), angiotensin receptor blockers (ARBs), calcium channel blockers (CCBs) and diuretics in all patients with diabetes mellitus. However, the effectiveness of these agents in South Asian and Chinese populations is unknown. We sought to determine whether ACEi, ARB, CCB and diuretics are associated with reduced mortality in South Asian, Chinese and other patients with diabetes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Design<\/jats:title>\n                    <jats:p>Population-based cohort study using administrative health databases.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Setting<\/jats:title>\n                    <jats:p>Province of British Columbia, Canada (2006\u20132013).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Participants<\/jats:title>\n                    <jats:p>Patients aged \u226535 years with incident diabetes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Primary and secondary outcome measures<\/jats:title>\n                    <jats:p>Primary outcome was all-cause mortality for each medication class compared with untreated patients within each ethnicity. Treatment effect was assessed using inverse probability of treatment weighted Cox proportional hazards models. Medication adherence effect on mortality was also evaluated.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>208\u2009870 patients (13 755 South Asian, 22 871 Chinese, 172\u2009244 other Canadian) were included. ACEi reduced mortality in other patients (HR=0.88, 0.84\u20130.91), but power was insufficient to evaluate for benefit in Chinese and South Asian patients. ARB and diuretics reduced mortality in Chinese (ARB HR=0.64, 0.50\u20130.82; diuretics HR=0.77, 0.62\u20130.96) and other patients (ARB HR=0.69, 0.64\u20130.74; diuretics HR=0.66, 0.63\u20130.69) compared with untreated patients. No mortality benefit was observed among South Asians for any drug class or for CCB among all ethnicities. Higher medication adherence was associated with lower mortality for other patients only (HR=0.79, 0.72\u20130.86).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Effectiveness of cardiovascular risk reduction therapy on mortality varies considerably by ethnicity. Further study is needed to evaluate the mortality benefit of antihypertensive agents in South Asians. Inclusion of these ethnic groups in future clinical trials is essential to examine for differential responses.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/bmjopen-2016-013808","type":"journal-article","created":{"date-parts":[[2017,8,31]],"date-time":"2017-08-31T20:20:12Z","timestamp":1504210812000},"page":"e013808","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":8,"title":["Is cardiovascular risk reduction therapy effective in South Asian, Chinese and other patients with diabetes? A population-based cohort study from Canada"],"prefix":"10.1136","volume":"7","author":[{"given":"Calvin H","family":"Ke","sequence":"first","affiliation":[{"name":"Department of Medicine, University of Toronto, Toronto, Ontario, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Steve","family":"Morgan","sequence":"additional","affiliation":[{"name":"School of Population and Public Health, University of British Columbia, Vancouver, British Columbia, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kate","family":"Smolina","sequence":"additional","affiliation":[{"name":"School of Population and Public Health, University of British Columbia, Vancouver, British Columbia, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Danijela","family":"Gasevic","sequence":"additional","affiliation":[{"name":"Centre for Population Health Sciences, University of Edinburgh, Edinburgh, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hong","family":"Qian","sequence":"additional","affiliation":[{"name":"Centre for Health Evaluation and Outcomes Sciences, University of British Columbia, Vancouver, British Columbia, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nadia A","family":"Khan","sequence":"additional","affiliation":[{"name":"Centre for Health Evaluation and Outcomes Sciences, University of British Columbia, Vancouver, British Columbia, Canada"},{"name":"Department of Medicine, University of British Columbia, Vancouver, British Columbia, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2017,8,31]]},"reference":[{"key":"2025120521325018000_7.8.e013808.1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1001286"},{"key":"2025120521325018000_7.8.e013808.2","doi-asserted-by":"publisher","DOI":"10.2337\/dc16-S001"},{"key":"2025120521325018000_7.8.e013808.3","unstructured":"Internal clinical guidelines Team. Type 2 diabetes in adults [Internet]. United Kingdom: National Institute for Health and Care Excellence; 2015 Dec, Report No: NG28. https:\/\/www.nice.org.uk\/guidance\/ng28\/resources\/type-2-diabetes-in-adults-management-pdf-1837338615493 (accessed 10 May 2017)."},{"key":"2025120521325018000_7.8.e013808.4","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/j.jcjd.2013.01.009","article-title":"Canadian Diabetes Association 2013 clinical practice guidelines for the prevention and management of diabetes in Canada. introduction","volume":"37","author":"Cheng","year":"2013","journal-title":"Can J Diabetes"},{"key":"2025120521325018000_7.8.e013808.5","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabres.2012.10.001"},{"key":"2025120521325018000_7.8.e013808.6","doi-asserted-by":"publisher","DOI":"10.1001\/jama.293.13.1595"},{"key":"2025120521325018000_7.8.e013808.7","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.165.12.1401"},{"key":"2025120521325018000_7.8.e013808.8","doi-asserted-by":"crossref","DOI":"10.1186\/1741-7015-11-141","article-title":"Why do hypertensive patients of African ancestry respond better to calcium blockers and diuretics than to ACE inhibitors and \u03b2-adrenergic blockers? A systematic review","volume":"11","author":"Brewster","year":"2013","journal-title":"BMC Med"},{"key":"2025120521325018000_7.8.e013808.9","doi-asserted-by":"publisher","DOI":"10.2217\/pgs.12.206"},{"key":"2025120521325018000_7.8.e013808.10","first-page":"217","article-title":"Racial differences in response to antihypertensive therapy: does one size fits all?","volume":"1","author":"Gupta","year":"2010","journal-title":"Int J Prev Med"},{"key":"2025120521325018000_7.8.e013808.11","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.317.7160.713"},{"key":"2025120521325018000_7.8.e013808.12","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199803053381003"},{"key":"2025120521325018000_7.8.e013808.13","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/S0140-6736(99)12323-7","article-title":"Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: results of the HOPE study and MICRO-HOPE substudy","volume":"355","author":"Heart Outcomes Prevention Evaluation (HOPE) Study Investigators","year":"2000","journal-title":"The Lancet"},{"key":"2025120521325018000_7.8.e013808.14","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0801317"},{"key":"2025120521325018000_7.8.e013808.15","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0804593"},{"key":"2025120521325018000_7.8.e013808.16","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjcard.2004.08.059"},{"key":"2025120521325018000_7.8.e013808.17","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2010.02.046"},{"key":"2025120521325018000_7.8.e013808.18","unstructured":"International Diabetes Federation. IDF Diabetes Atlas [Internet]. 2015 http:\/\/www.diabetesatlas.org\/component\/attachments\/?task=download&id=116 (accessed 6 May 2017)."},{"key":"2025120521325018000_7.8.e013808.19","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1007\/s11739-016-1422-x","article-title":"Systematic review: antihypertensive drug therapy in patients of African and South Asian ethnicity","volume":"11","author":"Brewster","year":"2016","journal-title":"Intern Emerg Med"},{"key":"2025120521325018000_7.8.e013808.20","unstructured":"BC Ministry of Health Data Stewardship Committee, BC Vital StatisticsAgency.. Consolidation File (MSP Registration & Premium Billing);Discharge Abstracts Database (Hospital Separations) and MedicalServices Plan (MSP) Payment Information File; PharmaNet; VitalStatistics Deaths [Internet]. 2012-2014 http:\/\/www.popdata.bc.ca\/data"},{"key":"2025120521325018000_7.8.e013808.21","unstructured":"Lindsay C . The South Asian community in Canada [Internet]. Ottawa: Social and Aboriginal Statistics Division, Statistics Canada; 2001, Report No: 89\u2013621\u2013XIE. http:\/\/www.statcan.gc.ca\/pub\/89-621-x\/89-621-x2007006-eng.htm#4 (accessed 10 May 2017)."},{"key":"2025120521325018000_7.8.e013808.22","unstructured":"Lindsay C . The Chinese community in Canada [Internet]. Ottawa: Social and Aboriginal Statistics Division, Statistics Canada; 2001, Report No: 89\u2013621\u2013XIE. http:\/\/www.statcan.gc.ca\/pub\/89-621-x\/89-621-x2006001-eng.htm (accessed 10 May 2017)."},{"key":"2025120521325018000_7.8.e013808.23","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1111\/dme.12559","article-title":"Prescribing patterns and adherence to medication among South-Asian, Chinese and white people with type 2 diabetes mellitus: a population-based cohort study","volume":"31","author":"Chong","year":"2014","journal-title":"Diabet Med J Br Diabet Assoc"},{"key":"2025120521325018000_7.8.e013808.24","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1016\/S0140-6736(07)60361-4","article-title":"Trends in diabetes prevalence, incidence, and mortality in Ontario, Canada 1995\u20132005: a population-based study","volume":"369","author":"Lipscombe","year":"2007","journal-title":"The Lancet"},{"key":"2025120521325018000_7.8.e013808.25","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabres.2010.03.007"},{"key":"2025120521325018000_7.8.e013808.26","doi-asserted-by":"publisher","DOI":"10.2337\/dc10-0865"},{"key":"2025120521325018000_7.8.e013808.27","doi-asserted-by":"crossref","DOI":"10.1186\/1471-2288-10-42","article-title":"Surname lists to identify South Asian and Chinese ethnicity from secondary data in Ontario, Canada: a validation study","volume":"10","author":"Shah","year":"2010","journal-title":"BMC Med Res Methodol"},{"key":"2025120521325018000_7.8.e013808.28","unstructured":"Milan A , Maheux H , Chui T . A portrait of couples in mixed unions. can Soc Trends [Internet]. 2010 Apr 20. 2010;89 http:\/\/www.statcan.gc.ca\/pub\/11-008-x\/2010001\/article\/11143-eng.htm."},{"key":"2025120521325018000_7.8.e013808.29","unstructured":"Government of Canada SC. Tables by subject: ethnic diversity and immigration [Internet]. 2013 http:\/\/www.statcan.gc.ca\/tables-tableaux\/sum-som\/l01\/ind01\/l2_30000-eng.htm (accessed 6 May 2017)."},{"key":"2025120521325018000_7.8.e013808.30","doi-asserted-by":"publisher","DOI":"10.1186\/1472-6963-8-79"},{"key":"2025120521325018000_7.8.e013808.31","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1007\/BF03324736","article-title":"Are comorbidity indices useful in predicting all-cause mortality in type 2 diabetic patients? comparison between Charlson index and disease count","volume":"19","author":"Monami","year":"2007","journal-title":"Aging Clin Exp Res"},{"key":"2025120521325018000_7.8.e013808.32","doi-asserted-by":"publisher","DOI":"10.1016\/j.cjca.2012.10.012"},{"key":"2025120521325018000_7.8.e013808.33","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.i189","article-title":"Inverse probability weighting","volume":"352","author":"Mansournia","year":"2016","journal-title":"BMJ"},{"key":"2025120521325018000_7.8.e013808.34","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1097\/EDE.0b013e31824cc1c3","article-title":"Effect of physical activity on functional Performance and knee pain in patients with osteoarthritis: analysis with marginal structural models","volume":"23","author":"Mansournia","year":"2012","journal-title":"Epidemiology"},{"key":"2025120521325018000_7.8.e013808.35","first-page":"666","article-title":"Standardization as a tool for causal inference in medical research","volume":"19","author":"Gharibzadeh","year":"2016","journal-title":"Arch Iran Med"},{"key":"2025120521325018000_7.8.e013808.36","doi-asserted-by":"publisher","DOI":"10.1002\/sim.5984"},{"key":"2025120521325018000_7.8.e013808.37","doi-asserted-by":"publisher","DOI":"10.1097\/MLR.0b013e31817924d2"},{"key":"2025120521325018000_7.8.e013808.38","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1016\/S0140-6736(02)08090-X","article-title":"Cardiovascular morbidity and mortality in patients with diabetes in the Losartan intervention for endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol","volume":"359","author":"Lindholm","year":"2002","journal-title":"The Lancet"},{"key":"2025120521325018000_7.8.e013808.39","doi-asserted-by":"publisher","DOI":"10.2337\/diacare.294836"},{"key":"2025120521325018000_7.8.e013808.40","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.109.850297"},{"key":"2025120521325018000_7.8.e013808.41","doi-asserted-by":"publisher","DOI":"10.1093\/ije\/dyp139"},{"key":"2025120521325018000_7.8.e013808.42","doi-asserted-by":"publisher","DOI":"10.1007\/s40256-013-0024-5"},{"key":"2025120521325018000_7.8.e013808.43","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1016\/j.ijcard.2014.07.114","article-title":"Cardiovascular mortality in hypertensive patients newly prescribed perindopril vs. lisinopril: a 5-year cohort study of 15,622 Chinese subjects","volume":"176","author":"Tsoi","year":"2014","journal-title":"Int J Cardiol"},{"key":"2025120521325018000_7.8.e013808.44","first-page":"340","article-title":"Barriers to healthcare and transnational ties: a case study of South korean immigrants in Toronto, Canada","volume":"133","author":"Wang","year":"2015","journal-title":"Soc Sci Med 1982"},{"key":"2025120521325018000_7.8.e013808.45","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehs114"},{"key":"2025120521325018000_7.8.e013808.46","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1600177"},{"key":"2025120521325018000_7.8.e013808.47","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1097\/EDE.0b013e3181c1ea43","article-title":"The hazards of hazard ratios","volume":"21","author":"Hern\u00e1n","year":"2010","journal-title":"Epidemiol Camb Mass"}],"container-title":["BMJ Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjopen-2016-013808","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,6]],"date-time":"2025-12-06T05:33:01Z","timestamp":1764999181000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjopen.bmj.com\/lookup\/doi\/10.1136\/bmjopen-2016-013808"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,8]]},"references-count":47,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2017,8,31]]},"published-print":{"date-parts":[[2017,8]]}},"alternative-id":["10.1136\/bmjopen-2016-013808"],"URL":"https:\/\/doi.org\/10.1136\/bmjopen-2016-013808","relation":{},"ISSN":["2044-6055","2044-6055"],"issn-type":[{"type":"print","value":"2044-6055"},{"type":"electronic","value":"2044-6055"}],"subject":[],"published":{"date-parts":[[2017,8]]}}}